Panagora Asset Management Inc Next Cure, Inc. Transaction History

Panagora Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$6.74 - $8.02 $22,605 - $26,899	-3,354 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$7.6 - $10.28 $31,342 - $42,394	-4,124 Reduced 55.15%	3,354 $27,000
Q1 2021 May 12, 2021	SELL	$9.81 - $13.88 $76,164 - $107,764	-7,764 Reduced 50.94%	7,478 $75,000
Q4 2020 Feb 10, 2021	SELL	$9.47 - $12.43 $31,307 - $41,093	-3,306 Reduced 17.82%	15,242 $166,000
Q3 2020 Nov 13, 2020	SELL	$8.15 - $21.17 $375,217 - $974,645	-46,039 Reduced 71.28%	18,548 $163,000
Q2 2020 Aug 12, 2020	BUY	$21.19 - $40.2 $1.36 Million - $2.59 Million	64,395 Added 33539.06%	64,587 $1.39 Million
Q3 2019 Nov 12, 2019	BUY	$15.73 - $41.6 $3,020 - $7,987	192 New	192 $6,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.